Glutathione-sensitive hollow mesoporous silica nanoparticles for controlled drug delivery.
J Control Release
; 282: 62-75, 2018 07 28.
Article
in En
| MEDLINE
| ID: mdl-29679666
Tunable glutathione (GSH)-sensitive hollow mesoporous silica nanoparticles (HMSiO2 NPs) were developed using a structural difference-based selective etching strategy. These organosilica hollow nanoparticles contained disulfide linkages (S-S) in the outer shell which were degraded by GSH. The particles were compared with their nonGSH-sensitive tetraethyl orthosilicate (TEOS) HMSiO2 counterparts in terms of their synthesis method, characterization, doxorubicin (DOX) release profile, and in vitro cytotoxicity in MCF-7 breast cancer cells. Transmission electron microscopy (TEM) of the particles indicated that the fabricated HMSiO2 NPs had an average diameter of 130⯱â¯5â¯nm. Thermogravimetric analysis (TGA) revealed that GSH-sensitive particles had approximately 5.3% more weight loss than TEOS HMSiO2 NPs. Zeta potential of these redox-responsive particles was -23⯱â¯1â¯mV at pHâ¯6 in deionized (DI) water. Nitrogen adsorption-desorption isotherm revealed that the surface area of the hollow mesoporous nanoreservoirs was roughly 446⯱â¯6â¯m2â¯g-1 and the average diameter of the pores was 2.3⯱â¯0.5â¯nm. TEM images suggest that the nanoparticles started to lose mass integrity from Day 1. The particles showed a high loading capacity for DOX (8.9⯱â¯0.5%) as a model drug, due to the large voids existing in the hollow structures. Approximately 58% of the incorporated DOX released within 14â¯days in phosphate buffered saline (PBS) at pHâ¯6 and in the presence of 10â¯mM of GSH, mimicking intracellular tumor microenvironment while release from TEOS HMSiO2 NPs was only c.a. 18%. The uptake of these hollow nanospheres by MCF-7 cells and RAW 264.7 macrophages was evaluated using TEM and confocal microscopy. The nanospheres were shown to accumulate in the endolysosomal compartments after incubation for 24â¯h with the maximum uptake of c.a. 2.1⯱â¯0.3% and 5.2⯱â¯0.4%, respectively. Cytotoxicity of the nanospheres was investigated using CCK-8 assay. Results indicate that intact hollow particles (both GSH-sensitive and TEOS HMSiO2 NPs) were nontoxic to MCF-7 cells after incubation for 24â¯h within the concentration range of 0-1000⯵gâ¯ml-1. DOX-loaded GSH-sensitive nanospheres containing 6⯵gâ¯ml-1 of DOX killed c.a. 51% of MCF-7 cells after 24â¯h while TEOS HMSiO2 NPs killed c.a. 20% with the difference being statistically significant. Finally, cytotoxicity data in RAW 264.7 macrophages and NIH 3â¯T3 fibroblasts shows that intact GSH-sensitive HMSiO2 NPs did not show any toxic effects on these cells with the concentrations equal or <125⯵gâ¯ml-1.
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Doxorubicin
/
Silicon Dioxide
/
Delayed-Action Preparations
/
Nanoparticles
/
Glutathione
/
Antibiotics, Antineoplastic
Type of study:
Diagnostic_studies
Limits:
Animals
/
Female
/
Humans
Language:
En
Journal:
J Control Release
Journal subject:
FARMACOLOGIA
Year:
2018
Document type:
Article
Affiliation country:
United States
Country of publication:
Netherlands